Malaria and other vector-borne infection surveillance in the U.S. Department of Defense Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance program: review of 2009 accomplishments

Vector-borne infections (VBI) are defined as infectious diseases transmitted by the bite or mechanical transfer of arthropod vectors. They constitute a significant proportion of the global infectious disease burden. United States (U.S.) Department of Defense (DoD) personnel are especially vulnerable to VBIs due to occupational contact with arthropod vectors, immunological naiveté to previously unencountered pathogens, and limited diagnostic and treatment options available in the austere and unstable environments sometimes associated with military operations. In addition to the risk uniquely encountered by military populations, other factors have driven the worldwide emergence of VBIs. Unprecedented levels of global travel, tourism and trade, and blurred lines of demarcation between zoonotic VBI reservoirs and human populations increase vector exposure. Urban growth in previously undeveloped regions and perturbations in global weather patterns also contribute to the rise of VBIs. The Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance and Response System (AFHSC-GEIS) and its partners at DoD overseas laboratories form a network to better characterize the nature, emergence and growth of VBIs globally. In 2009 the network tested 19,730 specimens from 25 sites for Plasmodium species and malaria drug resistance phenotypes and nearly another 10,000 samples to determine the etiologies of non-Plasmodium species VBIs from regions spanning from Oceania to Africa, South America, and northeast, south and Southeast Asia. This review describes recent VBI-related epidemiological studies conducted by AFHSC-GEIS partner laboratories within the OCONUS DoD laboratory network emphasizing their impact on human populations.

[1]  Lars Eisen,et al.  Proactive Vector Control Strategies and Improved Monitoring and Evaluation Practices for Dengue Prevention , 2009, Journal of medical entomology.

[2]  T. Klein,et al.  Soochong virus: An antigenically and genetically distinct hantavirus isolated from Apodemus peninsulae in Korea , 2006, Journal of medical virology.

[3]  R. Tesh,et al.  Guaroa virus infection among humans in Bolivia and Peru. , 2010, The American journal of tropical medicine and hygiene.

[4]  M. Cetron,et al.  Spectrum of disease and relation to place of exposure among ill returned travelers. , 2006, The New England journal of medicine.

[5]  K. Morita,et al.  First case of Dengue virus infection in Nepal. , 2004, Nepal Medical College journal : NMCJ.

[6]  S. Bennett,et al.  Characterization of Imjin Virus, a Newly Isolated Hantavirus from the Ussuri White-Toothed Shrew (Crocidura lasiura) , 2009, Journal of Virology.

[7]  N. Day,et al.  Artemisinin resistance: current status and scenarios for containment , 2010, Nature Reviews Microbiology.

[8]  S. Lee,et al.  Biological resistance of hydroxychloroquine for Plasmodium vivax malaria in the Republic of Korea. , 2009, The American journal of tropical medicine and hygiene.

[9]  C. Wongsrichanalai,et al.  In vivo sensitivity monitoring of mefloquine monotherapy and artesunate–mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003 , 2006, Tropical medicine & international health : TM & IH.

[10]  A. Schmidt Response to dengue fever--the good, the bad, and the ugly? , 2010, The New England journal of medicine.

[11]  Kate E. Jones,et al.  Global trends in emerging infectious diseases , 2008, Nature.

[12]  B. Sharp,et al.  Intercontinental Spread of Pyrimethamine-Resistant Malaria , 2004, Science.

[13]  J. Small,et al.  The AFHSC-Division of GEIS Operations Predictive Surveillance Program: a multidisciplinary approach for the early detection and response to disease outbreaks , 2011, BMC public health.

[14]  David A. Relman,et al.  Vector-borne diseases: understanding the environmental, human health, and ecological connections. Workshop summary. , 2008 .

[15]  N. Nagelkerke,et al.  UvA-DARE ( Digital Academic Repository ) Dengue as a cause of acute undifferentiated fever in Vietnam , 2006 .

[16]  W. Sames,et al.  Muju virus, a novel hantavirus harboured by the arvicolid rodent Myodes regulus in Korea. , 2007, The Journal of general virology.

[17]  M. Fukuda,et al.  Evidence of artemisinin-resistant malaria in western Cambodia. , 2008, The New England journal of medicine.

[18]  John C. Wootton,et al.  Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum , 2002, Nature.

[19]  R. Jarman,et al.  Identification of All Dengue Serotypes in Nepal , 2008, Emerging infectious diseases.

[20]  A. Fauci,et al.  The challenge of emerging and re-emerging infectious diseases , 2010, Nature.

[21]  M. McMorrow,et al.  Malaria acquired in Haiti - 2010. , 2010, MMWR. Morbidity and mortality weekly report.

[22]  M. Turell,et al.  Hemorrhagic Fever with Renal Syndrome in 4 US Soldiers , 2009 .

[23]  R. Lampman,et al.  Fundamental issues in mosquito surveillance for arboviral transmission. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[24]  P. Ringwald,et al.  Efficacy of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia , 2006, Tropical medicine & international health : TM & IH.

[25]  A. Bryceson,et al.  Fever as the presenting complaint of travellers returning from the tropics. , 1995, QJM : monthly journal of the Association of Physicians.

[26]  M. Turell,et al.  Hemorrhagic fever with renal syndrome in 4 US soldiers, South Korea, 2005. , 2009, Emerging infectious diseases.

[27]  C. Wongsrichanalai,et al.  Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia , 2009, Malaria Journal.

[28]  R. Snow,et al.  The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya , 2007, Malaria Journal.

[29]  D. Vaughn,et al.  Infectious diseases investment decision evaluation algorithm: a quantitative algorithm for prioritization of naturally occurring infectious disease threats to the U.S. military. , 2008, Military medicine.

[30]  G. van der Groen,et al.  Hemorrhagic fever with renal syndrome. , 2020, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.